$11.10
N/A
Dern. MÀJ: Oct 20, 5:00 PM
$11.10
N/A
Design Therapeutics (DSGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.35 | $-0.34 | $-0.36 | $-0.34 |
| Actual | $-0.32 | $-0.29 | $-0.27 | $-0.30 |
| Surprise | +8.57% | +14.7% | +25.0% | +11.8% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.35 | $-0.41 | $-0.41 | $-0.42 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 3, 2026 | $-0.32 | $-0.35 | 8.57 % |
| Q1 | Apr 28, 2026 | $-0.29 | $-0.34 | 14.7 % |
| Q4 | Mar 9, 2026 | $-0.27 | $-0.36 | 25.0 % |
| Q3 | Nov 5, 2025 | $-0.30 | $-0.34 | 11.8 % |